Skip to main content

Table 1 Comparison of relative factors between the two groups

From: PSAT1 enhances the efficacy of the prognosis estimation nomogram model in stage-based clear cell renal cell carcinoma

Variables

Early stage

Late stage

t/χ2

P value

Age (years)

59.58 ± 12.69

61.59 ± 11.40

1.798

0.073

Gender

  

0.429

0.513

 Male

197 (65.0)

133 (67.9)

  

 Female

106 (35.0)

63 (32.1)

  

Ethnic

  

4.599

0.100

 White

264 (87.1)

182 (92.9)

0.036

0.850

 Asian

5 (1.7)

3 (1.5)

0.596

0.440

 Black

34 (11.2)

11 (5.6)

4.587

0.032

Grade

  

108.968

< 0.001*

 G1

12 (4.0)

0 (0.0)

2.793

0.131

 G2

174 (57.4)

41 (20.9)

37.089

< 0.001*

 G3

104 (34.3)

93 (47.5)

27.863

< 0.001*

 G4

13 (4.3)

62 (31.6)

34.522

< 0.001*

 G1 + G2

186 (61.4)

41 (20.9)

78.60

< 0.001*

 G3 + G4

137 (38.6)

155 (79.1)

  

Neoadjuvant

  

0.117

0.732

 Yes

11 (3.1)

6 (3.6)

  

 No

292 (96.9)

190 (96.4)

  

PSAT1 Expression

  

23.065

< 0.001*

 High

125 (41.3)

124 (63.3)

  

 Low

178 (58.7)

72 (36.7)

  

PRAME Expression

  

40.711

< 0.001*

 High

117 (38.6)

133 (67.9)

  

 Low

186 (61.4)

63 (32.1)

  

KDELR3 Expression

  

29.854

< 0.001*

 High

122 (40.3)

128 (65.3)

  

 Low

181 (59.7)

68 (34.7)

  
  1. *Statistically significant P < 0.05